RJFSA
DRNA

Raymond James Financial Services Advisors’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History

Raymond James Financial Services Advisors’s Portfolio DRNA Stock Details DRNA Fund Activity
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-15,010
Closed -$560K – 3362
2021
Q2 		$560K Buy
15,010
+1,115
+8% +$41.6K ﹤0.01% 2294
2021
Q1 		$355K Buy
+13,895
New +$355K ﹤0.01% 2519